Your search for major depressive disorder returned 6 results

Botulinum toxin injections can improve quality of life for patients across a variety of aspects of health care, including pain management, urology, dermatology, and more.

Anxiety, depressive, and panic disorders are all common psychiatric comorbidities found in patients with migraine and headache disorders.

Researchers sought to synthesize the current circadian features of cluster headache and migraine, with a focus on timing of attacks, chronotype, corticosteroids, melatonin, core circadian genes, and clock controlled genes.

Researchers sought to evaluate the efficacy and safety of galcanezumab in patients with migraine in Japan.

In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.

In a systematic review, researchers examined the efficacy of digital headache management interventions for patients with a primary headache disorder.